Advertisement

ASCO GI 2023

Sorafenib Plus TACE May Control HCC After Resection

Jan 27, 2023

REFERENCES & ADDITIONAL READING

  1. Peng Z, et al. Adjuvant Transarterial Chemoembolization with Sorafenib for Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombus after Surgery: A Phase III, Multicenter, Randomized, Controlled Trial. Abstract 493, ASCO GI 2023, 19–21 January, San Francisco, CA, USA.

Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement